REHOVOT, Israel, March 21, 2022 /PRNewswire/ — ClearCut Medical Ltd., a developer of revolutionary, transportable MRI techniques for intraoperative margin evaluation in most cancers surgical procedure, is happy to announce the appointment of Hezi Himelfarb as CEO along side the corporate’s transition from a improvement stage to business stage firm.
Bringing greater than 30 years of administration expertise in hi-tech and medical system corporations, Himelfarb’s final position was CEO of O2Cure, the primary and solely firm that develops blood oxygenators from long-term ECMO operation as much as a man-made lung. Previous to O2Cure, Hezi served as Normal Supervisor and Chief Working Officer in Microbot Medical (Nasdaq traded) that developed a novel system for individuals affected by Hydrocephalus. Previous to Microbot, Himelfarb was CEO of IceCure Medical (Nasdaq and TASE traded) that develops superior cryotherapy techniques in ladies’s well being and different areas. Previous to IceCure, Himelfarb was the CEO of Remon Medical Applied sciences (offered to Boston Scientific) after spending 4 years in Medtronic-InStent Israel.
Himelfarb holds a B.Sc. in digital engineering and an M.B.A, each from Tel-Aviv College.
“ClearCut’s success up to now has been pushed by an extremely robust workforce. As we put together for the commercialization of our ClearCoastTM intra-operative MRI system, we’re completely happy to be including world class med-tech government who will lay the inspiration for our future success. Hezi’s expertise creating and commercializing revolutionary medical applied sciences in personal and public corporations is an ideal match for ClearCut,” stated Chairman, Mike Berman. “His confirmed skill to construct worth in venture-backed corporations and navigate regulatory, reimbursement and early market commercialization environments might be a useful asset.”
“ClearCut’s ClearCoast™ System is poised to make a serious impression on most cancers surgical procedure and scientific pathology,” famous Himelfarb. “The workforce has executed an exceptional job creating and clinically testing this vital breakthrough in MRI know-how kind issue, and in establishing robust scientific and strategic relationships that would be the foundation for world adoption beginning with the European launch this 12 months. It’s thrilling to hitch such a proficient workforce.”
About Clear-Lower Medical
Clear-Lower Medical, a medical system firm based mostly in Rehovot, Israel is devoted for enhancing the standard of look after most cancers sufferers by means of its novel intra-operative MRI know-how. The corporate has developed the compact, cellular, inexpensive and simple to make use of ClearCoastTM system for excised tissue evaluation. The system makes use of state-of-the-art proprietary MRI know-how for actual time tissue margin evaluation. Medical trial leads to breast conserving surgical procedure have proven excessive sensitivity and specificity and it will likely be commercialized with the target of considerably lowering the necessity for repeat surgical procedure in lumpectomy sufferers.
SOURCE Clear-Lower Medical